Introduction
Osteoarthritis (OA) is a highly prevalent disease, causing mobility limitations and decreased quality of life. However, interventions that prevent or modify the development of OA are not available. Pharmacological therapy is limited to anti-inflammatory and pain medications (Zhang et al., 2010) .
Oxidative stress has been established as an important factor in aging-associated diseases. Oxygen radical production is elevated in joint tissues including articular cartilage with aging and OA (Carlo and Loeser, 2003; Lepetsos and Papavassiliou, 2016; Scott et al., 2010) . Oxidative stress in OA is related to cellular senescence and to the expression of catabolic factors such as inflammatory cytokines and ECM grading proteases (Loeser et al., 2016) . Recently, several studies with transgenic mice have shown that approaches to enhance antioxidant capacity reduce OA severity (Cai et al., 2015; Koike et al., 2015; Takada et al., 2015) . Heme oxygenase-1 (HO-1) is an enzyme in heme catabolism that has a variety of physiological activities collectively referred to as cytoprotection via antioxidant, anti-apoptosis, and anti-inflammatory effects (Loboda et al., 2016) . Protective functions of HO-1 were reported in OA chondrocytes (Fernández et al., 2003; Guillén et al., 2008; Megías et al., 2009 ). We also reported that the constitutive expression of HO-1 in chondrocytes and meniscus in mice reduces severity of joint degeneration with aging (Ochiai et al., 2008; Takada et al., 2015) . These findings suggested that pharmacological HO-1 induction could support joint health via antioxidant induction and maintenance of cellular homeostasis. While cobalt protoporphyrin IX (CoPP) is a well-known HO-1 inducer, it is not suitable as a therapeutic agent because of adverse activities (Schmidt, 2007) . Carnosic acid (CA), is a natural diterpene in rosemary, with antioxidant, neuroprotector, and anti-angiogenic effects which appear to be beneficial in cancer, neurodegenerative disorders and diabetes (Bahri et al., 2016; Kelsey et al., 2010) . However, potential effects of CA on HO-1 pathway and beneficial effects of CA in OA have not been examined. The objective of this study was to define the effect of CA on HO-1 and mediators of OA pathogenesis in articular chondrocytes.
Materials and methods

Human tissues and cell culture
Studies using human tissues were approved by the Scripps Human Subjects Institutional Review Board. Normal human chondrocytes were isolated from autopsy donors as material and with no interactions with subjects, and therefore informed consent was not required. Human chondrocytes were cultured as described previously (Maier et al., 1993) in Dulbecco's modified Eagle's medium (Wako, Osaka, Japan) containing 10% fetal bovine serum, and Antibiotic-Antimycotic Mixed Stock Solution (100 ×) (Wako) at 37°C in a humidified atmosphere of 5% CO 2 . Experiments with human articular chondrocytes were carried out at passage 1. CA isolated from Rosmarinus officinalis was purchased from Sigma-Aldrich. CA was dissolved in DMSO (0.5%) as stock solution (20 mM).
Cell viability assessment by MTT assay
Articular chondrocytes were plated in 96-well plates and cultured with CA (1-50 μM) for 48 h. For MTT assay, 25 μl of fresh MTT (5 mg/ ml in PBS, Sigma-Aldrich) was added to each well. Five hours later, supernatant was aspirated, and 100 μl of DMSO was added to each well. The absorbance values were measured at 540 nm.
Immunoblotting assay
Human chondrocytes were plated at 5 × 10 4 per well into 24 well plates. Cells were treated with CA and/or stimulated with interleukin-1β (IL-1β, 1 ng/ml). After incubation for 24 h, the cells were washed with PBS, and proteins were extracted using M-PER™ protein extraction reagent including protease inhibitor cocktail (Thermo Fisher Scientific). (Miyaki et al., 2009) were transfected into human articular chondrocytes or HEK293T cells with Lipofectamine RNAiMax (Thermo Fisher Scientific) according to the manufacturer's instructions. Silencer Negative Control siRNA#1 (siNega, Thermo Fisher Scientific) was included in each experiment.
RNA preparation and quantitative real-time PCR
Human chondrocytes were plated at 5 × 10 4 per well into 24 well plates and treated with CA and / or stimulated with IL-1β (1 ng/ml). After incubation for 24 h, cells were washed with PBS, and total RNA was isolated with TRIzol RNA Isolation Reagents (Thermo Fisher Scientific). Complementary DNA (cDNA) was synthesized using 500 ng of total RNA with Superscript VILO kit (Thermo Fisher Scientific) according to the manufacturer's protocol. Real-time PCR assay was performed using TaqMan Gene Expression Assays probes (Thermo Fisher Scientific) for HMOX1 (Hs01110250_m1), COL2A1 (Hs01064869_m1), ACAN (Hs00202971_m1), MMP-13 (Hs00233992_m1), ADAMTS-5 (Hs00199841_m1), IL-1β (Hs00174097_m1), IL-6 (Hs00985639_m1), and GAPDH (Hs02758991_m1). Real-time PCR for miR-140 was performed using the TaqMan MicroRNA Reverse Transcription kit (Thermo Fisher Scientific). GAPDH or U6 snRNA were used as internal controls to normalize sample differences. The ΔΔCt method was used for analysis of real-time PCR data.
Nanostring nCounter miRNA analysis
Total RNA was used as input for the nCounter Human miRNA Expression Assay Kit (NanoString Technologies). The miRNA expression profiles were analyzed according to manufacturer's instructions.
Glycosaminoglycan release assay
Femoral heads were harvested from 3-week-old C57BL6 mice and incubated at 37°C for 48 h in 48-well plates. Animal experiments were performed according to protocols approved by the Hiroshima University Animal Care and Use Committee. Each well contained 500 μl of DMEM with 10% FBS. The cartilage explants were washed 3 times, and cultured at 37°C for an additional 72 h in 500 μl of serum-free DMEM containing CA with or without IL-1β (5 ng/ml). Serum-free DMEM with 0.5% DMSO used as control. After incubation for 72 h, conditioned medium was collected. The concentration of the released glycosaminoglycan in the conditioned medium was measured using the Blyscan Glycosaminoglycan assay kit (Biocolor, UK).
Luciferase assay
The target sequence of BACH1 was inserted at the 3'-UTR of Firefly luciferase into vector pLV.PRLb. FFL, which also expressed Renilla luciferase as internal control (Supplemental Fig. 1 ). Human embryonic kidney HEK293T cells in 96-well plates were transfected with 50 ng of reporter plasmid and stimulated with CA or the dsRNA. Luciferase activity was measured using Dual-Luciferase Reporter Assay System (Promega).
Statistical analysis
The data were analyzed by the one-way ANOVA or Steel-Dwass. Differences were considered statistically significant at *= P < 0.05 and ** = P < 0.01.
Results
Carnosic acid induces HO-1 expression in human articular chondrocytes
To test whether CA induces the expression of HO-1 in articular chondrocytes, we performed immunoblotting assay. The expression of HO-1 in articular chondrocytes was increased by CA in a dose-dependent manner (Fig. 1A, B) . Treatment with CA (1-50 μM) did not affect chondrocyte viability (Fig. 1C) . The expression of HO-1 in articular chondrocytes was significantly increased CA at 10 and 50 μM (Fig. 1D) .
IL-1β is induces expression of mediators of OA pathogenesis (Goldring and Otero, 2011) . IL-1β treatment significantly decreased the expression of HO-1 in articular chondrocytes. CA restored HO-1 levels under IL-1β treatment (Fig. 1D ).
Chondroprotective effects of carnosic acid in articular chondrocytes
We further investigated whether CA attenuates IL-1β-induced OAlike changes in articular chondrocytes. CA significantly downregulated the IL-1β induced expression of MMP-13 and ADAMTS-5 ( Fig. 2A) . Furthermore, to examine chondroprotective effects of CA, we quantified glycosaminoglycan release from mouse femoral head cartilage explants. IL-1β significantly increased proteoglycan release (Fig. 2B ) but CA (10 and 50 μM) significantly suppressed this IL-1β effect (Fig. 2B) . These results suggest that CA attenuates the degradation of cartilage by inhibiting the expression of key enzymes, MMP-13 and ADAMTS5 and by reducing GAG release.
Carnosic acid induces the expression of HO-1 by downregulation of Bach1 via miR-140
The expression of HO-1 gene (HMOX-1) is negatively regulated by BTB and CNC homology 1 (BACH1), a transcriptional repressor, which binds to HMOX-1 enhancers (Sun et al., 2002) . We recently showed that Bach1 deficiency in mice reduces OA severity through upregulation of HO-1 (Takada et al., 2015) . MicroRNAs (miRNA) function as negative regulators of gene expression by promoting mRNA degradation and/or repressing translation of target genes. To examine whether miRNAs are involved in the upregulation of HO-1 by CA, we performed gene expression profiling using the NanoString system and searched the TargetScan prediction program (http://targetscan.org) for candidate miRNAs regulating BACH1. The expression of several miRNAs was upregulated in articular chondrocytes with CA treatment (Table 1) . This included miR-140 which has predicted BACH1 binding sites in the 3'UTR (Fig. 3A) . CA induced the expression of miR-140 in articular chondrocytes (Fig. 3B ) and miR-140 mimic significantly decreased the expression of BACH1 in chondrocytes (Fig. 3C) . To determine whether BACH1 is a direct target gene of miR-140, the full length 3'UTR of BACH1, which includes the putative miR-140 binding site was cloned downstream from the luciferase gene in an expression vector. In HEK293T cells transfected with full length 3'UTR of BACH1 CA significantly reduced luciferase activity (Fig. 3D) . Furthermore, the putative miR-140 binding site in the BACH1 3'UTR was cloned downstream of the luciferase gene in an expression vector. MiR-140 mimic significantly reduced luciferase activity in HEK293T cells with full length of BACH1 3'UTR or tandem miR-140 binding site (Figs. 3E, 3F) . No changes in luciferase activity were observed in cells transfected with three different types of mutated sensor vector (Fig. 3F, Supplemental  Fig) . These results suggest a model where CA induces the expression of miR-140 which suppressed BACH1 and this increases HO-1 expression in chondrocytes (Fig. 4) .
Discussion
Enhancing the expression of antioxidant enzymes in articular chondrocytes is a potential therapeutic approach in OA (Cai et al., 2015; Koike et al., 2015; Takada et al., 2015) . The expression of HO-1, a key mediator of antioxidant defense, decreases with aging in articular cartilage and menisci of mouse knees (Takada et al., 2015) , and decreased HO-1 accelerates chondrocyte hypertrophic differentiation and Runx2 expression (Kim et al., 2013) . On the other hand, the constitutive expression of HO-1 in mouse chondrocytes and meniscus reduces severity of joint damage with aging (Ochiai et al., 2008; Takada et al., 2015) . These findings suggest that maintaining, HO-1 expression may have beneficial effects for OA prevention during aging. Overexpression or induction of HO-1 has anti-inflammatory activities (Benallaoua et The present results show that IL-1β decreased the expression of HO-1 in chondrocytes. However, CA antagonized this IL-1β effect. The upregulation of HO-1 by CA was associated with inhibition of cartilage degradation through downregulation of extracellular matrix degrading enzymes such as MMP-13 and ADAMTS-5. The present observations are consistent with previous studies on HO-1 upregulation in chondrocytes (Clérigues et al., 2013; Guillén et al., 2008; Megías et al., 2009 ). Although CA 50 μM strongly induced HO-1, the expression of the cartilage anabolic gene ACAN was significantly downregulated by CA 50 μM. Thus, CA 50 μM does not appear to be an optimal concentration for protective effects on chondrocytes. We recently showed that Bach1 deficiency in mice reduces OA severity by HO-1 suppression and associated increases in antioxidant activities and decreases in extracellular matrix degrading enzymes (Takada et al., 2015) . These results strongly support the notion that induction of HO-1 by CA is an effective therapeutic agent for OA prevention.
CA activates the nuclear factor erythroid 2-related factor 2 (Nrf2) transcription factor, which upregulates several enzymes involved in the maintenance of the redox state such as γ-glutamyl cysteine ligase (γ-GCL), NAD(P)H:quinone oxidoreductase 1 (NQO1), glutathione peroxidase (GPx), glutathione reductase (GR), and Mn-superoxide dismutase (SOD2), and HO-1 (Loboda et al., 2016) . CA regulates the expression of HO-1 through the KEAP1/NRF2 transcriptional pathway by binding to specific KEAP1 cysteine residues (Mimura et al., 2011; Satoh et al., 2008) .
The expression of HO-1 is also negatively regulated by Bach1, a transcriptional repressor, which binds to HO-1 enhancers (Sun et al., 2002) . Bach1 deficient mice thus have high constitutive HO-1 expression in various tissues including cartilage under physiological conditions (Sun et al., 2002; Takada et al., 2015) . MiRNAs are also negative regulators of gene expression by promoting degradation or repressing translation of target mRNAs (Siomi and Siomi, 2010) . Our present results showed that miR-140 regulates HO-1 expression through binding to 3'UTR of BACH1. It was recently reported that miR-155 and miR196a regulate the expression of HO-1 through reduction of BACH1 in endothelial cells or hepatoma cells (Hou et al., 2010; Pulkkinen et al., 2011) . Although these miRNAs have predicted binding sites in the 3'UTR of BACH1, CA did not induce miR-155 or miR-196a in chondrocytes (Table 1) . MiR-155 is one of inflammatory miRNAs, and is upregulated in joint tissues including cartilage stimulated with inflammatory cytokines (D'Adamo et al., 2016; Kurowska-Stolarska et al., 2011; Stanczyk et al., 2008) . TNFα upregulated the expression of HO-1 and miR-155 in endothelial cells (Pulkkinen et al., 2011) , however, IL-1β downregulated the expression of HO-1 in articular chondrocytes in the present study. Thus, the regulation of Bach1-mediated HO-1 expression by miRNA might depend on cell type and context. In addition, our previous study showed high levels of miR-140 expression in normal human articular cartilage and that miR-140 expression is significantly reduced in OA cartilage and in IL-1β-stimulated chondrocytes (Miyaki et al., 2009 ). Previously we also showed that miR-140 regulates cartilage development and homeostasis, and its loss contributes to the development of OA-like changes in transgenic mice (Miyaki et al., 2010) . The miR-140 deficiency in mice caused an early onset of OA through upregulation of direct target genes such as Adamts-5 and the expression of Bach1 was upregulated in chondrocytes from these mice (Miyaki Fig. 2 . Chondroprotective effects of carnosic acid in articular chondrocytes. A. Articular chondrocytes were treated with CA (10 and 50 μM) under IL-1β (1 ng/ml) for 24 h. The expression of Col2a1, AGGRECAN, MMP-13, ADAMTS-5, IL-1β and IL-6 were examined by quantitative real-time PCR analysis. Data represented as mean ± S.D., n = 4. Statistical analysis was performed with Steel-Dwass. * = P < 0.05 versus DMSO (control). B. Mouse femoral head cartilage explants (n = 6-8 each group) cultured with 10 or 50 μM of CA /or without with IL-1β (5 ng/ml) for 72 h. Proteoglycan release into the conditioned medium from cartilage was assayed as concentration of glycosaminoglycan (GAG). Data represented as mean ± S.D. Comparison of mean values was performed by Steel-Dwass. * = P < 0.05. The absolute GAG value of control (DMSO) is 799.9 ng/ml. et al., 2010) . In the present study, although HO-1 was significantly increased by 10 μM and 50 μM CA, the expression of miR-140 did not show a dose response to CA. Luciferase assays also did not show dose responses to CA or miR-140 mimic. Thus, increased expression of certain amounts of miR-140 might be sufficient for inhibition of BACH1. CA induced HO-1 might directly activate KEAP1/NRF2 pathway or inhibit BACH1 via miR-140. Our studies reveal a relationship between miR-140, BACH1 and HO-1 in chondrocytes for OA protection. MiR-140 directly regulates cartilage homeostasis through fine-tuning BACH1 and ADAMTS-5 levels in chondrocytes (Fig. 4) .
In conclusion, the present study demonstrated that CA, a natural diterpene in rosemary, upregulates HO-1 not only by the main KEAP1/ NRF2 pathway, but also through increasing miR-140 binding to 3'UTR of BACH1 in articular chondrocytes. These findings suggest that CA attenuates cartilage degeneration through upregulation of HO-1 and has potential as an agent for OA prevention. Fig. 4 . Schema of the putative mechanism of cartilage protection by carnosic acid. CA regulates the expression of HO-1 through KEAP1/NRF2 transcriptional pathway by binding to specific KEAP1 cysteine residues. The present study showed that CA induces HO-1 through upregulating miR-140, and miR-140 negatively regulates the expression of Bach1 by biding to Bach1 3'-UTR.
